<code id='2D78D33919'></code><style id='2D78D33919'></style>
    • <acronym id='2D78D33919'></acronym>
      <center id='2D78D33919'><center id='2D78D33919'><tfoot id='2D78D33919'></tfoot></center><abbr id='2D78D33919'><dir id='2D78D33919'><tfoot id='2D78D33919'></tfoot><noframes id='2D78D33919'>

    • <optgroup id='2D78D33919'><strike id='2D78D33919'><sup id='2D78D33919'></sup></strike><code id='2D78D33919'></code></optgroup>
        1. <b id='2D78D33919'><label id='2D78D33919'><select id='2D78D33919'><dt id='2D78D33919'><span id='2D78D33919'></span></dt></select></label></b><u id='2D78D33919'></u>
          <i id='2D78D33919'><strike id='2D78D33919'><tt id='2D78D33919'><pre id='2D78D33919'></pre></tt></strike></i>

          entertainment

          entertainment

          author:knowledge    Page View:3
          Glaxo Smith Kline
          Akira Suemori/AP

          A few years ago, Vijay Pande, then a professor at Stanford who was using computer science to understand biology, was deciding whether to leave full-time academic work to become a venture capitalist. He turned to Andrew Ng, another Stanford professor who had joined Google Brain and later the Chinese search firm Baidu.

          “The things that we dreamed about five or 10 years ago were happening now,” Pande recalled Ng telling him. “The question was, do you want to be a part of it? Or do you want to write another paper?”

          advertisement

          Pande decided to become a venture capitalist. The result, he told an audience at a STAT event in San Francisco last week, is that, whereas he managed about $1 million to $2 million in research as a top academic, he now works at the fabled Silicon Valley firm Andreessen Horowitz, which invests $100 million a year.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          knowledge

          BioMarin wins approval for gene therapy to treat hemophilia A
          BioMarin wins approval for gene therapy to treat hemophilia A

          AdobeTheFoodandDrugAdministrationonThursdayapprovedagenetherapytotreatpeoplewithhemophiliaA,aninheri

          read more
          Neurocrine Biosciences, biotech based in San Diego, joins PhRMA
          Neurocrine Biosciences, biotech based in San Diego, joins PhRMA

          NeurocrineBiosciencesdecidedtojoinPhRMA.AdobeWASHINGTON—NeurocrineBiosciences,abiotechcompanybasedin

          read more
          Hepatitis C has a cure — but many Americans still lack access to it
          Hepatitis C has a cure — but many Americans still lack access to it

          AdobeIn2005,NickVoyleswasdiagnosedwithhepatitisCafterbeingreleasedfromfiveyearsofincarceration.Anurs

          read more

          Alabama IVF ruling threatens families facing fatal genetic disease

          Henrywithhisparents.Illustration:STAT;Courtesy:AllenGoldbergWhenmywife,Laurie,completedherninthinvit